Skip to content

the Efficacy of Bupropion and Ritaline

Comparing the Efficacy of Bupropion and Ritaline on women Sexual Dysfunction Induced by serteralin)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170606034348N2
Enrollment
50
Registered
2018-09-19
Start date
2018-04-09
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual dysfunction. Sexual dysfunction not due to a substance or known physiological condition

Interventions

Intervention 1: "Intervention group 1": In female patients aged 20 to 45 years with sertraline treatment that has been associated with sexual dysfunction during treatment with this drug, Ritalin table
the Bupropion (wellban) tablet from the ?Abidi Pharmaceutical Company at a dose of 150 mg daily (evening) for one month is prescribed.

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Female patient aged 20 to 45 years undergoing treatment with sertraline

Exclusion criteria

Exclusion criteria: History of any previous sexual dysfunction Consumers of any drugs and cigarettes or herbal medicines Previous chronic diseas

Design outcomes

Primary

MeasureTime frame
Score of sexual dysfunction in Arizona Sexual Experiences Scale questionnaire. Timepoint: .End of one month after treatment begins. Method of measurement: Arizona Sexual Experiences Scale is a short 5-point scale that evaluates sexual performance, especially sexuality, arousal, orgasm's ability to achieve orgasm during the next week. Arizona Sexual Experiences Scale, a tool for assessing sexual misconduct due to side effects of drug interventions in patients with depression or anxiety disorder, is filled by a person in charge of the research.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAngela Hamidia

Babol University of Medical Sciences

a.hamidia@mubabol.ac.ir+98 11 3219 9596

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026